Compare ICHR & AXGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ICHR | AXGN |
|---|---|---|
| Founded | 1999 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.5B |
| IPO Year | 2016 | 2013 |
| Metric | ICHR | AXGN |
|---|---|---|
| Price | $48.43 | $30.76 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 9 |
| Target Price | ★ $40.67 | $36.11 |
| AVG Volume (30 Days) | ★ 1.2M | 835.6K |
| Earning Date | 05-06-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $947,652,000.00 | $225,208,000.00 |
| Revenue This Year | $16.08 | $17.30 |
| Revenue Next Year | $11.64 | $17.21 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 11.61 | ★ 20.21 |
| 52 Week Low | $13.15 | $9.22 |
| 52 Week High | $55.00 | $36.00 |
| Indicator | ICHR | AXGN |
|---|---|---|
| Relative Strength Index (RSI) | 63.67 | 38.31 |
| Support Level | $15.70 | $29.53 |
| Resistance Level | N/A | $34.70 |
| Average True Range (ATR) | 4.08 | 1.81 |
| MACD | -0.32 | -0.51 |
| Stochastic Oscillator | 55.63 | 23.95 |
Ichor Holdings Ltd designs, engineers, and manufactures critical fluid delivery subsystems and components mainly for semiconductor capital equipment, along with solutions for defense/aerospace and medical industries. Its product portfolio includes gas and chemical delivery subsystems that enable precise delivery, monitoring, and control of specialized gases and reactive liquid chemistries used in semiconductor manufacturing processes such as etch, electroplating, and cleaning. The company also provides precision-machined components, weldments, e-beam and laser-welded components, as well as precision vacuum and hydrogen brazing. Geographically, the company operates across the United States, Singapore, Europe, and other regions, with Singapore contributing the majority of revenue.
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.